Search results (250)
« Back to NewsStudy identifies immune–metabolic pathway as potential target in diabetic heart disease
19 March 2026
Researchers have shown that a drug originally developed to lower blood sugar can improve heart function and reduce inflammation in a preclinical model of type 2 diabetes.
New study reveals how blood cell production responds to parasite infection
11 March 2026
Research led by the Nerlov Group in the MRC Molecular Haematology Unit provides the first detailed explanation of how parasite-fighting immune cells are selectively increased following infection.
Paresh Vyas receives CRUK Discovery Programme Award
11 March 2026
Congratulations to Professor Paresh Vyas, who has been awarded a Discovery Research grant from Cancer Research UK to investigate cancer immunotherapies.
New bone marrow model offers scalable platform for next-generation drug discovery
24 February 2026
Researchers at the MRC Weatherall Institute of Molecular Medicine have developed the first combined human bone and bone marrow organoid platform capable of modelling long term blood and immune cell production in a fully human 3D system.
Study suggests blood pressure care after giving birth could protect brain health
19 January 2026
Women who develop high blood pressure during pregnancy may be able to protect their long term brain health through better blood pressure management soon after giving birth, according to a new study by Oxford researchers.
Why the body stops protecting itself against low blood sugar
13 January 2026
New RDM research reveals how prior hypoglycaemia weakens a key hormonal defence.
Night-time changes in metabolism may be driving common liver disease
12 January 2026
Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern, and the metabolic changes that drive the disease are most pronounced overnight, when the body is least able to process sugar and fat.
Iron supplement absorption preserved in children with HIV and boosted by prebiotics
13 November 2025
New research shows that iron from supplements and fortified foods is well-absorbed in children living with virally suppressed HIV, and that administering iron supplements with prebiotics may enhance their effectiveness and improve their safety.
Oxford scientists map the cells that drive Crohn’s disease fistulas
12 November 2025
Researchers at the MRC Translational Immune Discovery Unit have identified how rare populations of abnormal cells drive the formation and persistence of fistulas - painful, tunnel-like tracts that develop in around 30% of people with Crohn’s disease - paving the way for targeted treatments.
Abdullah Khan receives Wellcome Career Development Award
4 November 2025
Congratulations are in order for Dr Abdullah (Abs) Khan, who has been awarded a Wellcome Career Development Award for his research on age-related immune dysfunction using human model systems.
Professor Ellie Tzima receives Leducq Foundation funding to tackle Peripheral Artery Disease
28 September 2025
Professor Ellie Tzima from the Radcliffe Department of Medicine has joined an international team of scientists awarded an $8.5 million grant from the Leducq Foundation to study Peripheral Artery Disease (PAD) and accelerate the development of new therapies.
Oxford University to accelerate type 1 diabetes research and care with £10 million gift
25 September 2025
The University of Oxford has announced a gift of £10 million from the Bukhman Foundation to support ground-breaking research into type 1 diabetes (T1D). This generous funding will establish the Bukhman Centre for Research Excellence in Type 1 Diabetes, as well as create new academic posts and scholarships, helping to accelerate progress towards better treatments and ultimately a cure.
Body-in-a-chip approach reveals how immune cells respond to heart injury
11 September 2025
Oxford scientists build a connected, ‘multi-organoid’ platform that recreates immune recruitment to the heart, opening new avenues to probe disease and test therapies.
Weight loss alone doesn’t ease atrial fibrillation symptoms in older adults, study finds
29 August 2025
A clinical trial led by researchers in the University of Oxford’s Radcliffe Department of Medicine and Oxford Population Health, has found that while a structured weight-loss programme helped older adults with atrial fibrillation (AF) shed weight safely and sustainably, it did not improve their heart rhythm symptoms or reduce the need for further treatment.
Scientists reveal how new diabetes and obesity drugs work
19 August 2025
A team led by scientists at the University of Oxford and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie in Berlin has used fluorescent versions of next-generation diabetes and obesity drugs to reveal, for the first time, exactly which cells they target in the pancreas and brain.
Platelets shown to store DNA in study that could transform cancer screening
15 August 2025
Study led by Psaila Group uncovers previously unknown function of platelets as DNA ‘vacuum cleaners’ in the blood, with profound implications for cancer diagnosis and prenatal screening.
Wellcome Discovery Award for Claus Nerlov
31 July 2025
Claus Nerlov, Professor of Stem Cell Biology, has been awarded funding from Wellcome to map the gene regulatory networks in blood cell production and seek new therapeutic targets.